These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7783156)

  • 21. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists.
    Masłowska-Lipowicz I; Walczyński K
    Chem Biol Drug Des; 2014 Jan; 83(1):106-18. PubMed ID: 23957330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of rat gastric adenylate cyclase by histamine and histamine analogues and blockade by burimamide.
    McNeil JH; Verma SC
    Br J Pharmacol; 1974 Sep; 52(1):104-6. PubMed ID: 4451768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade by burimamide of the effects of clonidine on cardiac contractility phosphorylase activation and cyclic adenosine monophosphate in isolated guinea pig heart.
    Verma SC; McNeill JH
    Indian J Physiol Pharmacol; 1980; 24(2):77-83. PubMed ID: 6247271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives.
    Goto T; Sakashita H; Murakami K; Sugiura M; Kondo T; Fukaya C
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):305-11. PubMed ID: 9118445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theophylline derivatives as potential histamine H3-receptor antagonists.
    Kieć-Kononowicz K; Cegła MT
    Pharmazie; 1998 Aug; 53(8):518-21. PubMed ID: 9741061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of potent non-thiourea H3-receptor histamine antagonists.
    Ganellin CR; Hosseini SK; Khalaf YS; Tertiuk W; Arrang JM; Garbarg M; Ligneau X; Schwartz JC
    J Med Chem; 1995 Aug; 38(17):3342-50. PubMed ID: 7650687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of histamine uptake and metabolism by burimamide in the guinea-pig atrium and in mouse neoplastic mast cells, in vitro.
    Fantozzi R; Mannaioni PF; Moroni F
    Br J Pharmacol; 1973 Oct; 49(2):361-3. PubMed ID: 4152220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
    Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
    J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.
    Wieland K; Bongers G; Yamamoto Y; Hashimoto T; Yamatodani A; Menge WM; Timmerman H; Lovenberg TW; Leurs R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):908-14. PubMed ID: 11714875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some chemical aspects of histamine H2-receptor antagonists.
    Ganellin CR; Durant GJ; Emmett JC
    Fed Proc; 1976 Jun; 35(8):1924-30. PubMed ID: 5312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
    Stark H; Purand K; Ligneau X; Rouleau A; Arrang JM; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1996 Mar; 39(5):1157-63. PubMed ID: 8676353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of H2-receptor antagonists in the feedback of histamine [proceedings].
    Allouche G; Santais MC; Foussard C; Ruff F; Parrot JL
    Agents Actions; 1977 Mar; 7(1):103-4. PubMed ID: 193384
    [No Abstract]   [Full Text] [Related]  

  • 34. Antinociceptive activity of derivatives of improgran and burimamide.
    Hough LB; Nalwalk JW; Leurs R; Menge WM; Timmerman H
    Pharmacol Biochem Behav; 2000 Jan; 65(1):61-6. PubMed ID: 10638637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conformational approach to histamine H2-receptor antagonists.
    Bianucci AM; Martinelli A; Da Settimo A
    Farmaco Sci; 1984 Aug; 39(8):686-95. PubMed ID: 6148263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mepyramine, a histamine H1-, and burimamide, a histamine H2-receptor antagonist, on ovum implantation in the rat.
    Brandon JM; Wallis RM
    J Reprod Fertil; 1977 Jul; 50(2):251-4. PubMed ID: 881662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of two H3-histamine receptor subtypes.
    West RE; Zweig A; Shih NY; Siegel MI; Egan RW; Clark MA
    Mol Pharmacol; 1990 Nov; 38(5):610-3. PubMed ID: 2172771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.
    Guryn R; Staszewski M; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel class (H3) of histamine receptors on perivascular nerve terminals.
    Ishikawa S; Sperelakis N
    Nature; 1987 May 14-20; 327(6118):158-60. PubMed ID: 3033517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.